Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 329 companies set new 52-week lows.
Top 10 Highest Short Interest Stocks And 10 With Highest Cost To Borrow: Where Do Carvana, MicroStrategy, Fisker And AMC Rank?
Investors often look for stocks with high short interest and a high cost to borrow, which could predict a potential short squeeze. New data shared by S3 Partners could signal which stocks investors are betting heavily against.
Benzinga’s Top Ratings Upgrades, Downgrades For December 12, 2022
Upgrades For Colliers International Group Inc (NASDAQ:CIGI), Goldman Sachs upgraded the previous rating of Neutral to Buy. Colliers…
HC Wainwright & Co. Maintains Buy on Allogene Therapeutics, Lowers Price Target to $29
HC Wainwright & Co. analyst Debjit Chattopadhyay maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and lowers the price target from $43 to $29.
Allogene Therapeutics Launches CAR T Together, A First-Of-Its-Kind Initiative With Oncologists Nationwide, Focused On Accelerating Development And Clinical Trial Recruitment For “Off-The-Shelf” Allogeneic Cell Therapy Investigational Products
New Survey Focused on Access Limitations of Approved Autologous CAR T Therapies Reveals Only 50% of Eligible Cancer Patients Receive Treatment
Increased Patient Demand, Manufacturing Capacity and Time to
B. Riley Securities Maintains Buy on Allogene Therapeutics, Lowers Price Target to $18
B. Riley Securities analyst Kalpit Patel maintains Allogene Therapeutics (NASDAQ:ALLO) with a Buy and lowers the price target from $21 to $18.
